Other
DNA Methylation
DNA Methylation is an intervention with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(1)
Other(3)
Detailed Status
unknown3
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Trials by Status
recruiting120%
unknown360%
completed120%
Recent Activity
1 active trials
Showing 5 of 5
completed
Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer
NCT03622385
recruiting
Precision Medicine for Every Child With Cancer
NCT05504772
unknown
Epigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis C
NCT04220151
unknown
DNA Methylation for Screening Uterine Cervical Lesions
NCT03960879
unknown
DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study
NCT03961191
Clinical Trials (5)
Showing 5 of 5 trials
NCT03622385
Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer
NCT05504772
Precision Medicine for Every Child With Cancer
NCT04220151
Epigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis C
NCT03960879
DNA Methylation for Screening Uterine Cervical Lesions
NCT03961191
DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5